IMP-3 oligopeptides and vaccines including the same

Details for Australian Patent Application No. 2010327878 (hide)

Owner Oncotherapy Science, Inc.

Inventors Nishimura, Yasuharu; Harao, Michiko; Tomita, Yusuke; Nakamura, Yusuke; Tsunoda, Takuya

Agent Davies Collison Cave

Pub. Number AU-A-2010327878

PCT Pub. Number WO2011/067920

Priority 61/371,434 06.08.10 US; 61/265,657 01.12.09 US

Filing date 30 November 2010

Wipo publication date 9 June 2011

International Classifications

C07K 7/06 Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61P 35/00 Antineoplastic agents

C12N 15/00 Mutation or genetic engineering

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/067920 Priority application(s): WO2011/067920

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010327891-MYBL2 peptides and vaccines containing the same

2010327767-Device for separating and recovering carbon dioxide